Outcome of T1N0M0 Squamous Cell Carcinoma of the Larynx Treated with Short-course Radiotherapy to a Total Dose of 50 Gy in 16 Fractions: the Birmingham Experience

Clinical Oncology

Volumn 21, Issue 6, 2009, Pages 494-501

  Cheah, N L C ^a   Lupton, S ^a   Marshall, A ^b   Hartley, A ^a   Glaholm, J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Cancer; glottis; hypofractionated radiotherapy; larynx; squamous cell carcinoma

Indexed keywords

COBALT 60;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RELAPSE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SALVAGE THERAPY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; TREATMENT OUTCOME;

EID: 67649659730     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.02.008     Document Type: Article

References (33)

1. Cancer Research UK. Available at: http://info.cancerresearchuk.org/cancerstats/types/larynx/incidence/ [Accessed 14.04. 2008].
2. Williams M.V., Summers E.T., Drinkwater K., and Barrett A. Radiotherapy dose fractionation, access and waiting times in the countries of the UK in 2005. Clin Oncol (R Coll Radiol) 19 (2007) 273-286
3. Fowler J.F. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling. Clin Oncol (R Coll Radiol) 19 (2007) 8-22
4. Gowda R.V., Henk J.M., Mais K.L., Sykes A.J., Swindell R., and Slevin N.J. Three weeks' radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital experience. Radiother Oncol 68 (2003) 105-111
5. Short S., Krawitz H., Macann A., et al. T1N0/2TN0 glottic carcinoma: a comparison of two fractionation schedules. Australas Radiol 50 (2006) 152-157
6. Colasanto J.M., Haffty B.G., and Wilson L.D. Evaluation of local recurrence and second malignancy in patients with T1 and T2 squamous cell carcinoma of the larynx. Cancer J 10 (2004) 61-66
7. Mendenhall W.M., Amdur R.J., Morris C.G., and Hinerman R.W. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19 (2001) 4029-4036
8. Jørgensen K., Godballe C., Hansen O., and Bastholt L. Cancer of the larynx - treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol 41 (2002) 69-76
9. Dinshaw K.A., Sharma V., Agarwal J.P., Ghosh S., and Havaldar R. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. Int J Radiat Oncol Biol Phys 48 (2000) 723-735
10. Spector J.G., Sessions D.G., Chao K.S., et al. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck 21 (1999) 707-717
11. Van der Voet J.C., Keus R.B., Hart A.A., Hilgers F.J., and Bartelink H. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys 42 (1998) 247-255
12. Warde P., O'Sullivan B., Bristow R.G., et al. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 41 (1998) 347-353
13. Nishimura Y., Nagata Y., Okajima K., et al. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control. Radiother Oncol 40 (1996) 225-232
14. Fein D.A., Mendenhall W.M., Parsons J.T., and Million R.R. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys 25 (1993) 605-611
15. Kim R.Y., Marks M.E., and Salter M.M. Early-stage glottic cancer: importance of dose fractionation in radiation therapy. Radiology 182 (1992) 273-275
16. Epstein B.E., Lee D.J., Kashima H., and Johns M.E. Stage T1 glottic carcinoma: results of radiation therapy or laser excision. Radiology 175 (1990) 567-570
17. Cellai E., Chiavacci A., and Olmi P. Causes of failure of curative radiation therapy in 205 early glottic cancers. Int J Radiat Oncol Biol Phys 19 (1990) 1139-1142
18. Johansen L.V., Overgaard J., Hjelm-Hansen M., and Gadeberg C.C. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys 18 (1990) 1307-1313
19. Schwaibold F., Scariato A., Nunno M., et al. The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys 14 (1988) 451-454
20. Ricciardelli E.J., Weymuller Jr. E.A., Koh W.J., Austin-Seymour M., DeSautel M.G., and Laramore G.E. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters. Arch Otolaryngol Head Neck Surg 120 (1994) 737-742
21. Roberts S.A., Hendry J.H., Brewster A.E., and Slevin N.J. The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor. Br J Radiol 67 (1994) 790-794
22. Duncan W., MacDougall R.H., Kerr G.R., and Downing D. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol 41 (1996) 203-207
23. Royal College of Radiologists. Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy. 2nd edn (2002), Royal College of Radiologists, London
24. Mendenhall W.M., Parsons J.T., Million R.R., and Fletcher G.H. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys 15 (1988) 1267-1273
25. Franchin G., Minatel E., Gobitti C., et al. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer 98 (2003) 765-772
26. Cohen S.M., Garrett C.G., Dupont W.D., Ossoff R.H., and Courey M.S. Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision. Ann Otol Rhinol Laryngol 115 (2006) 581-586
27. Ambrosch P. The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 15 (2007) 82-88
28. Kazi R., Venkitaraman R., Johnson C., et al. Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer. Radiother Oncol 87 (2008) 230-236
29. Cooper J.S., Pajak T.F., Rubin P., et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 17 (1989) 449-456
30. Feigenberg S.J., Lango M., Nicolaou N., and Ridge J.A. Intensity-modulated radiotherapy for early larynx cancer: is there a role?. Int J Radiat Oncol Biol Phys 68 (2007) 2-3
31. Lüscher M.S., Pedersen U., and Johansen L.V. Treatment outcome after laser excision of early glottic squamous cell carcinoma - a literature survey. Acta Oncol 40 (2001) 796-800
32. Chone C.T., Yonehara E., Martins J.E., Altemani A., and Crespo A.N. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection. Arch Otolaryngol Head Neck Surg 133 (2007) 882-887
33. UK Clinical Research Network: EaStER feasibility study early stage glottic cancer: endoscopic excision or radiotherapy. [Accessed 23.11.07].